XOMA Royalty (XOMA) Revenue (QoQ) (2011 - 2026)
XOMA Royalty (XOMA) Revenue (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.46% |
| Jun 30, 2025 | 25.63% |
| Mar 31, 2025 | 700.00% |
| Dec 31, 2024 | -93.05% |
| Sep 30, 2024 | 43.22% |
| Jun 30, 2024 | 237.25% |
| Mar 31, 2024 | 14.62% |
| Dec 31, 2023 | 477.78% |
| Sep 30, 2023 | -86.43% |
| Jun 30, 2023 | 279.41% |
| Mar 31, 2023 | -48.59% |
| Dec 31, 2022 | 88.47% |
| Sep 30, 2022 | -14.10% |
| Jun 30, 2022 | -80.91% |
| Mar 31, 2022 | 1,275.00% |
| Dec 31, 2021 | -63.64% |
| Sep 30, 2021 | -38.96% |
| Jun 30, 2021 | 140.27% |
| Mar 31, 2021 | -98.64% |
| Dec 31, 2020 | 4,851.53% |